Aarti Pharmalabs Limited has disclosed significant changes in promoter and promoter group shareholding following an acquisition. The total promoter holding, which stood at 42.88% before the acquisition, has been reduced to 39.66% as of September 21, 2026. This shift involves a sale of shares by Gloire Trusteeship Services Pvt Ltd and other promoters, partially offset by an acquisition of shares by other entities within the promoter group.
Promoter Shareholding Adjustment Detailed
Aarti Pharmalabs Limited has filed a disclosure detailing the acquisition and sale of shares by its promoter and promoter group entities. The disclosures, made under SEBI regulations, outline a shift in the collective shareholding of the promoter group. Prior to the acquisition period, the total shareholding of the promoter and promoter group was 42.88%.
Post-Acquisition Holding
Following a period of acquisition and sale between September 19, 2025, and September 21, 2026, the promoter and promoter group’s total shareholding in Aarti Pharmalabs Limited has adjusted. The aggregate holding now stands at 3,59,64,425 shares, representing 39.66% of the total diluted share capital. This represents a net decrease in the promoter group’s overall stake.
Key Transactions
The details reveal that Gloire Trusteeship Services Pvt Ltd (LOTUS FAMILY TRUST) sold shares amounting to 6,24,500 shares, resulting in a decrease of 0.69%. Additionally, other promoters and promoter group entities sold shares totaling 24,78,539 shares, a reduction of 2.73%. Conversely, an acquisition of 2,00,064 shares (0.22%) by other promoter group entities partially offset these sales. The net effect of these transactions has led to the revised promoter holding.
No Other Stake Changes
The disclosure also confirms that there were no changes in shares encumbered, voting rights otherwise than by shares, or warrants/convertible securities during the reporting period, with these categories remaining at 0.00%.
Source: BSE
